Shenzhen Bioeasy Biotechnology Co., Ltd. (SHE:300942)
China flag China · Delayed Price · Currency is CNY
9.80
-0.01 (-0.10%)
At close: Feb 13, 2026

SHE:300942 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
449.8293.4481.75247.45342.21379.1
Short-Term Investments
---181.91--
Trading Asset Securities
145.05302.92120.03-340.21-
Cash & Short-Term Investments
594.85596.31601.78429.36682.42379.1
Cash Growth
2.20%-0.91%40.16%-37.08%80.01%-14.28%
Accounts Receivable
100.4194.1176.284.0397.3764.02
Other Receivables
4.132.123.3615.176.57.13
Receivables
104.5496.2379.5699.2103.8771.15
Inventory
57.9140.4331.46100.6193.8661.59
Other Current Assets
18.0718.6424.8745.2517.4914.29
Total Current Assets
775.37751.62737.67674.42897.64526.13
Property, Plant & Equipment
577.24562.9426.52324.64143.4444.89
Long-Term Investments
84.48100.69145.18195.7621.943.51
Other Intangible Assets
37.7939.2441.3942.442.644.12
Long-Term Accounts Receivable
---3.61--
Long-Term Deferred Tax Assets
2.90.083.0614.97.47.34
Long-Term Deferred Charges
2.81.681.9314.311.4214.7
Other Long-Term Assets
0.970.960.5912.4228.0712.2
Total Assets
1,4821,4571,3561,2821,153652.89
Accounts Payable
74.8458.7677.3565.1155.6614.64
Accrued Expenses
17.6223.0823.9439.4546.7321.39
Current Portion of Long-Term Debt
31.9941.65.475.18--
Current Portion of Leases
--9.2818.614-
Current Income Taxes Payable
1.440.050.010.019.744.45
Current Unearned Revenue
17.2925.118.6566.6127.5936.03
Other Current Liabilities
7.133.362.224.822.911.61
Total Current Liabilities
150.3151.96136.93199.78156.6378.12
Long-Term Debt
412.49426.39345.7856.32--
Long-Term Leases
--5.3439.2527.12-
Long-Term Unearned Revenue
6.336.516.5420.3322.1925.78
Other Long-Term Liabilities
2.082.083.022.08--
Total Liabilities
571.21586.92507.61317.75205.94103.9
Common Stock
405.07401.32400.86400.86400.86360
Additional Paid-In Capital
220.64190.22186.59178.7141.914.63
Retained Earnings
220.17209.14192.02385.43402.28183.81
Comprehensive Income & Other
62.2268.3369.52-0.09-0.280.61
Total Common Equity
908.09869.01848.99964.89944.76549.05
Minority Interest
2.261.24-0.27-0.191.82-0.07
Shareholders' Equity
910.35870.24848.73964.7946.58548.98
Total Liabilities & Equity
1,4821,4571,3561,2821,153652.89
Total Debt
444.49467.98365.87119.3441.12-
Net Cash (Debt)
150.36128.33235.91310.02641.31379.1
Net Cash Growth
-12.78%-45.60%-23.91%-51.66%69.17%-14.28%
Net Cash Per Share
0.350.300.590.781.631.04
Filing Date Shares Outstanding
405.07401.32400.86400.86400.86400.86
Total Common Shares Outstanding
405.07401.32400.86400.86400.86360
Working Capital
625.07599.66600.74474.64741.02448.01
Book Value Per Share
2.242.172.122.412.361.53
Tangible Book Value
870.3829.76807.6922.49902.16504.93
Tangible Book Value Per Share
2.152.072.012.302.251.40
Buildings
-330.0315.8715.8710.2410.24
Machinery
-87.0990.58106.5172.0857.18
Construction In Progress
-199.79356.63190.8751.34-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.